These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28346405)

  • 1. Structural and functional insight into human O-GlcNAcase.
    Roth C; Chan S; Offen WA; Hemsworth GR; Willems LI; King DT; Varghese V; Britton R; Vocadlo DJ; Davies GJ
    Nat Chem Biol; 2017 Jun; 13(6):610-612. PubMed ID: 28346405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into activity and inhibition from the crystal structure of human O-GlcNAcase.
    Elsen NL; Patel SB; Ford RE; Hall DL; Hess F; Kandula H; Kornienko M; Reid J; Selnick H; Shipman JM; Sharma S; Lumb KJ; Soisson SM; Klein DJ
    Nat Chem Biol; 2017 Jun; 13(6):613-615. PubMed ID: 28346407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human OGA binds substrates in a conserved peptide recognition groove.
    Schimpl M; Schüttelkopf AW; Borodkin VS; van Aalten DM
    Biochem J; 2010 Nov; 432(1):1-7. PubMed ID: 20863279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAcase: promiscuous hexosaminidase or key regulator of O-GlcNAc signaling?
    Alonso J; Schimpl M; van Aalten DM
    J Biol Chem; 2014 Dec; 289(50):34433-9. PubMed ID: 25336650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into the substrate binding adaptability and specificity of human O-GlcNAcase.
    Li B; Li H; Hu CW; Jiang J
    Nat Commun; 2017 Sep; 8(1):666. PubMed ID: 28939839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation.
    Gorelik A; Bartual SG; Borodkin VS; Varghese J; Ferenbach AT; van Aalten DMF
    Nat Struct Mol Biol; 2019 Nov; 26(11):1071-1077. PubMed ID: 31695185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation.
    Dorfmueller HC; Borodkin VS; Schimpl M; van Aalten DM
    Biochem J; 2009 May; 420(2):221-7. PubMed ID: 19275764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases.
    Dorfmueller HC; Borodkin VS; Schimpl M; Zheng X; Kime R; Read KD; van Aalten DM
    Chem Biol; 2010 Nov; 17(11):1250-5. PubMed ID: 21095575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into a strategy for attenuating AmpC-mediated beta-lactam resistance: structural basis for selective inhibition of the glycoside hydrolase NagZ.
    Balcewich MD; Stubbs KA; He Y; James TW; Davies GJ; Vocadlo DJ; Mark BL
    Protein Sci; 2009 Jul; 18(7):1541-51. PubMed ID: 19499593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domain.
    Rao FV; Schüttelkopf AW; Dorfmueller HC; Ferenbach AT; Navratilova I; van Aalten DM
    Open Biol; 2013 Oct; 3(10):130021. PubMed ID: 24088714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
    Li J; Li Z; Li T; Lin L; Zhang Y; Guo L; Xu Y; Zhao W; Wang P
    Biochemistry (Mosc); 2012 Feb; 77(2):194-200. PubMed ID: 22348480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the structural origin of the substrate sequence independence of O-GlcNAcase using a combination of molecular docking and dynamics simulation.
    Martin JC; Fadda E; Ito K; Woods RJ
    Glycobiology; 2014 Jan; 24(1):85-96. PubMed ID: 24134879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and Biochemical Strategies To Explore the Substrate Recognition of O-GlcNAc-Cycling Enzymes.
    Hu CW; Worth M; Li H; Jiang J
    Chembiochem; 2019 Feb; 20(3):312-318. PubMed ID: 30199580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lipid-droplet-targeted O-GlcNAcase isoform is a key regulator of the proteasome.
    Keembiyehetty CN; Krzeslak A; Love DC; Hanover JA
    J Cell Sci; 2011 Aug; 124(Pt 16):2851-60. PubMed ID: 21807949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
    Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
    Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
    Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
    PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.
    Laczy B; Marsh SA; Brocks CA; Wittmann I; Chatham JC
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1715-27. PubMed ID: 20833964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive inhibition of O-GlcNAcase isoforms by an alpha-GlcNAc thiolsulfonate.
    Kim EJ; Amorelli B; Abdo M; Thomas CJ; Love DC; Knapp S; Hanover JA
    J Am Chem Soc; 2007 Dec; 129(48):14854-5. PubMed ID: 17994748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.